A trend away from medical trials initiated by drug manufacturers towards investigator-initiated trials is one reason officials with Hamilton Health Sciences Corporation decided create a captive insurance company, a speaker told attendees at last week’s Captives and Corporate Insurance Strategies…
We use cookies to make your website experience better. By accepting this notice and continuing to browse our website you confirm you accept our Terms of Use & Privacy Policy.
read more >>